The global cannabidiol (CBD) market has witnessed significant growth over the past few years and is set to continue its upward trajectory. The market size is expected to reach US$8.9 billion by 2025, with projections indicating it will grow to US$28.7 billion by 2032, reflecting a robust CAGR of 18.2% during the forecast period from 2025 to 2032. This growth is driven by increasing consumer interest in wellness, personal care products, and nutraceuticals. Furthermore, rising awareness about natural and plant-based solutions, along with evolving regulatory frameworks and growing legalization in multiple regions, continue to fuel the expansion of the cannabidiol market.
Key Industry Highlights
The cannabidiol market has been marked by several prominent trends, particularly in terms of market segmentation and regional dominance.
Hemp Dominance: The hemp-derived CBD market is expected to account for 70% of the market share by 2025. This is driven by the widespread adoption of hemp CBD supplements and phytocannabinoid oil, which are legal in many regions and face fewer regulatory hurdles compared to marijuana-based products.
B2C Surge: Business-to-consumer (B2C) sales are projected to hold a dominant share, driven primarily by CBD-infused edibles, capsules, and gummies. These products cater to the growing demand for convenient wellness solutions.
Fastest-Growing End-use: The wellness segment is expected to witness rapid growth, driven by CBD products targeting pain management, stress relief, and overall well-being.
Regional Leadership: North America remains the dominant market, holding 50% of the global share in 2025, followed by Europe with a projected share of 25%.
Innovation Trends: The CBD-infused food and beverages market, along with functional beverages containing CBD, are expected to witness a 15% increase by 2025. The cannabidiol skincare and cosmetics market also continue to grow, boosting the CBD wellness segment by 12%.
Regulatory Impact: Regulatory advancements and the legalization of hemp-derived CBD in many regions are expected to accelerate market expansion, with predictions of 20% growth for hemp-derived CBD by 2025.
Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/34668
Market Dynamics
Driver: Increasing Legalization and Consumer Awareness of CBD Benefits
One of the key drivers of the cannabidiol market is the increasing legalization and growing consumer awareness of the therapeutic benefits of CBD. As more regions worldwide legalize hemp-derived CBD, the demand for cannabidiol products such as CBD oil for anxiety relief, CBD tinctures, and CBD supplements has surged.
In 2025, it is estimated that 30 countries will have legalized hemp-derived CBD. A survey conducted in 2025 revealed that 65% of consumers recognize the benefits of CBD for pain management and stress relief, driving the popularity of CBD products. The growing consumer interest in wellness is also fueling demand for CBD-infused food and beverages, functional beverages, and skincare products.
Restraint: Regulatory Uncertainty and High Production Costs
While the cannabidiol market is experiencing rapid growth, certain barriers may slow its expansion. Regulatory uncertainty remains a key restraint, particularly in regions with inconsistent rules governing the sale and use of CBD products. In the United States, for example, 20% of states have strict CBD regulations, limiting market growth.
Furthermore, the high production costs associated with the extraction and refinement of hemp-based CBD products are another challenge. The extraction process for high-quality CBD supplements can cost up to US$5,000 per kilogram, making it difficult to reduce prices and offer affordable products. Compliance with stringent regulations, particularly for CBD in pharmaceuticals and wellness, has increased costs by 12%, further impacting market growth.
Opportunity: Growth in Wellness Products and E-commerce Channels
The rise of CBD wellness products and the rapid growth of e-commerce platforms present significant opportunities for market expansion. The global wellness market, valued at approximately US$1.5 trillion in 2025, continues to fuel the demand for CBD products such as capsules, gummies, and skincare solutions.
E-commerce platforms are expected to play a pivotal role in enhancing accessibility and driving growth, particularly in emerging markets. Companies like Canopy Growth Corporation are investing heavily in research and development to expand their CBD product portfolios and meet growing consumer demand.
Category-wise Analysis
Source Type Insights
Hemp is the dominant source of CBD, representing approximately 70% of the market share in 2025. This is due to its legal status and widespread adoption in wellness products, including CBD oil for anxiety, pain management, and sleep support. Hemp-based CBD products are also more affordable and easier to produce compared to marijuana-based alternatives.
Marijuana-derived CBD, on the other hand, is expected to grow at a 20% rate by 2025, driven primarily by the increasing legalization of marijuana in North America and parts of Europe. Products derived from marijuana are believed to offer enhanced therapeutic benefits due to the “entourage effect.”
Sales Type Insights
B2C sales are projected to account for 60% of the market share by 2025. CBD edibles, capsules, and gummies are the leading product formats in this segment due to their convenience, ease of use, and discreet nature. E-commerce platforms and health stores are expected to be the primary channels for B2C sales, offering direct access to a wide variety of CBD wellness products.
End-use Insights
Wellness products represent a significant segment in the cannabidiol market, accounting for 40% of the market share in 2025. The demand for CBD skincare, cosmetics, and wellness products is growing rapidly due to the perceived benefits of CBD as a natural anti-inflammatory and antioxidant ingredient. The rise of the clean beauty movement and influencer-driven marketing campaigns has further accelerated the popularity of CBD in the beauty and personal care industry.
Pharmaceuticals is another key end-use segment, with companies investing heavily in clinical research to introduce CBD-based drugs for chronic pain, anxiety, epilepsy, and other neurological disorders.
Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/34668
Regional Insights
North America
North America is the largest market for cannabidiol products, accounting for 50% of the global share in 2025. The United States, in particular, dominates the market due to its progressive stance on CBD legalization, with the U.S. market expected to reach US$4.5 billion in 2025. The increasing adoption of CBD for stress relief, pain management, and wellness is driving growth in the region. Companies like Canopy Growth Corporation and ENDOCA are at the forefront of expanding the North American CBD market.
Europe
Europe holds 25% of the global market share, with countries such as Germany, France, and the United Kingdom leading the charge. Germany is the fastest-growing market in Europe, driven by the demand for CBD wellness products and tinctures. The European Union’s regulatory advancements are also boosting market growth, particularly for hemp-derived CBD, with €100 million earmarked for CBD research in 2025.
Asia Pacific
The Asia Pacific region is poised to become the fastest-growing market for cannabidiol products, with a projected CAGR of 21%. Japan, Australia, and South Korea are leading the charge in the region. Australia is seeing significant growth in CBD oil products for anxiety and stress relief, while South Korea is embracing CBD-infused functional beverages.
Competitive Landscape
The cannabidiol market is characterized by intense competition, with companies competing primarily on innovation, product quality, and regulatory compliance. ENDOCA and Canopy Growth Corporation are major players in the hemp-derived CBD supplement market, while Elixinol leads the way in CBD skincare and cosmetics.
Key players in the market are focusing on strategic partnerships, research and development, and product innovations to gain a competitive edge.
Key Industry Developments
Canopy Growth Corporation launched a new line of CBD capsules and gummies in August 2024, aimed at capitalizing on the growing demand for convenient wellness products.
Elixinol expanded its wellness portfolio in April 2023 by introducing CBD-infused skincare and cosmetic products, targeting the beauty and personal care segment.
Endoca strengthened its presence in the Asia Pacific market in 2022 by expanding its portfolio of hemp-derived CBD supplements tailored to regional preferences and compliance standards.
Key Players in the Market
ENDOCA
Canopy Growth Corporation
Elixinol
NuLeaf Naturals LLC
The Cronos Group
Medical Marijuana Inc.
Isodiol International Inc.
PharmaHemp
Folium Europe B.V.
Future Outlook
The global cannabidiol market is on a robust growth path, driven by increasing consumer demand for natural wellness products, regulatory developments, and innovations in CBD-based food, beverages, and cosmetics. With emerging markets poised for significant expansion and continued innovation in product formats and delivery systems, the cannabidiol market is expected to maintain its upward trajectory well into the next decade.
